Mitomycin C (MMC) and Unconventional Fractionation (V-Chart) in Advanced Head and Neck Cancer
Open Access
- 1 January 1995
- journal article
- research article
- Published by Informa UK Limited in Acta Oncologica
- Vol. 34 (2), 270-272
- https://doi.org/10.3109/02841869509093973
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Intercomparisons of new and old schedules in fractionated radiotherapySeminars in Radiation Oncology, 1992
- The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: An interim reportInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Cell repopulation and overall treatment timeInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Continuous hyperfractionated accelerated radiotherapy in locally advanced carcinoma of the head and neck regionInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Randomized clinical trial of mitomycin c as an adjunct to radiotherapy in head and neck cancerInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometryBritish Journal of Cancer, 1988
- Tumor hypoxia: its impact on cancer therapyCancer and Metastasis Reviews, 1987
- Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality: (Preliminary report) by the radiation therapy oncology group (RTOG)International Journal of Radiation Oncology*Biology*Physics, 1987
- The significance of anemia in clinical radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Radiotherapy with thrice-a-day fractionation in a short overall time: Clinical experiencesInternational Journal of Radiation Oncology*Biology*Physics, 1981